Policy & Regulation
MyDx names Jessica Peatross as CMO
12 January 2018 -

Chemical detection company MyDx Inc (OTC:MYDX) disclosed on Thursday the appointment of Jessica Peatross as its chief medical officer.

In the company's medical department, Dr Peatross will lead the clinical research initiatives, support formulation services to MyDx360 Customers, as well as offer doctor consultation for its customers through the MyDx App, including the possibility of writing medical cannabis prescriptions in all legal states.

Currently, Dr Peatross is a western trained, board certified medical doctor, a Gerson Therapy practitioner, a consultant in San Diego's premiere Nourish Medical Center as well as owns and operates an organically formulated nutraceutical line of products tailored to treating various chronic symptoms and illnesses.

Previously, Dr Peatross worked as a traditional doctor supporting patients in a level 1 trauma centre for six years as well as practised functional medicine with Optimal Health and Wellness and Whitiker Wellness.



Related Headlines